Insurance
Medication adherence and insurance costs
Medication non-adherence can increase avoidable complications, wasted prescriptions, and preventable care costs for health systems.
Insurer cost opportunity
CHF 174mof the 2024 savings target remains open
Helsana's 2025 report points to a gap insurers can make actionable with earlier medication-routine signals, targeted support, and cost-aware adherence workflows.
Make adherence risk visible earlier
Daily intake records give prevention teams a signal before claims data arrives late.
Focus support where it matters
Exception-based workflows help insurers route coaching to members and medicines with visible routine risk.
Connect routines to cost-aware care
Substitution and refill conversations become easier to support when medication routines are clear.
Open savings opportunity
CHF 174m still open against the target
Target
CHF 250m
70%
CHF 174m still open
Realized
CHF 76m
Still open
CHF 174m
Substitution potential
CHF 65m
Helsana figures describe Swiss medication-cost and substitution context. They are not measured Adherlo outcome data.
Prevention depends on consistent intake
For chronic conditions, medication only delivers value when it is taken consistently. Better adherence can support preventive care strategies.
Aggregated insights reveal risk patterns
Population-level adherence trends can help insurers identify where education, support, or targeted programs may reduce avoidable costs.
Patient trust remains essential
Insurance programs should be transparent about data use and focus on support, not punishment, if they want durable engagement.
Explore adherence partnerships
Adherlo works with partners interested in better adherence, patient support, and data-informed prevention.